Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage

Completed · Phase 1

Conditions studied: Actinic Keratoses, Photodamage

In brief

To provide a treatment of both actinic keratoses and photodamage within one treatment.

Key facts

Study ID

NCT07053852

Run by

Sherrif Ibrahim

People needed

10

Starts

2025-06-27

Expected to finish

2025-12-29

Last updated by the study team

2026-01-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Over 18yrs of age
• Willingness to participate in all required study activities and visits
• Willingness to sign the informed consent form
• Visible and palpable signs of diffuse actinic damage and actinic keratoses of mild to moderate severity located on the face
• Significant signs of photoaging, evaluated by investigator, that include any or all the following:
• Dyspigmentation
• Solar lentigines
• Telangiectasias
• Diffuse erythema
• Roughness and other textural changes
• Fine lines
• Wrinkles
• Actinic bronzing

You may not qualify if…

• Subject who is unable and unwilling to provide consent for study schedule and procedures
• Subject who is pregnant or trying to become pregnant during the study
• Subjects using any topical treatment on their AKs; must stop at least one month prior
• Subjects currently undergoing cancer treatment with medical or radiation therapy
• Subjects with a known hypersensitivity to 5-aminolevulinic acid or any component of the study material
• Subjects with history of a photosensitivity disease, such as porphyria cutanea tarda

Where it is running

• Rochester Dermatologic Surgery — Victor, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.